Tissue engineering's green shoots of disruptive innovation

The Lancet

Volumn 384, Issue 9940, 2014, Pages 288-290

  Birchall, Martin A ^a   Seifalian, Alexander M ^b  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE SCAFFOLD;

ANGIOGENESIS; CARTILAGE GRAFT; HEALTH CARE SYSTEM; HUMAN; NOTE; ORGAN TRANSPLANTATION; PLASTIC SURGERY; PRIORITY JOURNAL; TISSUE ENGINEERING; FEMALE SEXUAL FUNCTION INDEX; HEALTH CARE INDUSTRY; MUSCLE CELL; NUCLEAR MAGNETIC RESONANCE SCANNER; QUALITY OF LIFE; QUESTIONNAIRE; SKIN CANCER; SKIN FLAP; TISSUE REPAIR; VASCULAR PEDICLE;

46, XX DISORDERS OF SEX DEVELOPMENT; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MALE; MULLERIAN DUCTS; NASAL CARTILAGES; NOSE NEOPLASMS; SKIN NEOPLASMS; TISSUE ENGINEERING; VAGINA;

EID: 84904855804     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60533-X     Document Type: Note

References (12)

1. Raya-Rivera AM, Esquiliano D, Fierro-Pastran R, et al. Tissue-engineered autologous vaginal organs in patients: A pilot cohort study. Lancet 2014; published online April 11. http://dx.doi.org/10.1016/S0140-6736(14)60542-0.
2. Fulco I, Miot S, Haug MD, et al. Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: An observational fi rst-inhuman trial. Lancet 2014; published online April 11. http://dx.doi.org/10.1016/S0140- 6736(14)60544-4.
3. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaff olds. Annu Rev Biomed Eng 2011; 13: 27-53.
4. Centanni JM, Straseski JA, Wicks A, et al. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg 2011; 253: 672-83.
5. Olausson M, Patil PB, Kuna VK, et al. Transplantation of an allogeneic vein bioengineered with autologous stem cells: A proof-of-concept study. Lancet 2012; 380: 230-37.
6. Bhargava S, Patterson JM, Inman RD, MacNeil S, Chapple CR. Tissue-engineered buccal mucosa urethroplasty-clinical outcomes. Eur Urol 2008; 53: 1263-69.
7. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-46.
8. Delaere PR, Hermans R. Clinical transplantation of a tissue-engineered airway. Lancet 2009; 373: 717-18.
9. Jabir S, Frew Q, El-Muttardi N, Dziewulski P. A systematic review of the applications of free tissue transfer in burns. Burns 2014; published online Feb 8. DOI:10.1016/j.burns.2014.01.008.
10. Christensen CM, Bohmer R, Kenagy J. Will disruptive innovations cure health care? Harv Bus Rev 2000; 78: 102-12.
11. Christensen CM. The innovator's solution: creating and sustaining successful growth. Boston, MA: Harvard Business Press, 2003.
12. de Mel A, Seifalian AM, Birchall MA. Orchestrating cell/material interactions for tissue engineering of surgical implants. Macromol Biosci 2012; 12: 1010-21.